Decompression and Drainage Seton in the Treatment of High Complex Anal Fistula

October 22, 2021 updated by: Hui Li, China-Japan Friendship Hospital

Cutting Seton Versus Decompression and Drainage Seton in the Treatment of High Complex Anal Fistula

This study aimed to compare the efficacy of the decompression and drainage seton (DADS) and cutting seton (CS) in the treatment of high complex anal fistula.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100029
        • China-Japan Friendship Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • high trans-sphincteric cryptoglandular anal fistulas (involving >30% of the EAS muscles evaluated through magnetic resonance imaging (MRI) scan, endoanal ultrasonography)
  • suprasphincteric fistulas were enrolled

Exclusion Criteria:

  • Low anal fistula; -Non-glandular anal fistulas, such as tuberculous anal fistula and Crohn's anal fistula; -
  • Patients with symptoms of fecal incontinence;
  • A previous history of anal fistula surgical treatment;
  • Patients with malignant tumors or mental illness or other reasons unable to cooperate with the treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: decomprssion and drainage seton
Incision the internal sphincter over the fistula tract in intersphinteric space to achieve decompression then drainage seton will be put around external sphincter.
ACTIVE_COMPARATOR: Cutting seton
Cutting seton is introduced from outside openning to internal openning and encircling the internal and external anal sphincter.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of healing
Time Frame: 6 months post-operation.
complete healing was defined as complete epithelialization of the wound, with no evidence of external fistula opening or perianal discharge under physical examination.
6 months post-operation.
Recurrence rate
Time Frame: within 12 months after the procedure
recurrence was defined as the clinical reappearance of the fistula after complete healing, removal or fall-off of seton
within 12 months after the procedure
The healing time of the anal wound (days)
Time Frame: 6 months post-operation.
the time needed to achieve complete healing of anal fistula.
6 months post-operation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2016

Primary Completion (ACTUAL)

December 1, 2019

Study Completion (ACTUAL)

May 1, 2020

Study Registration Dates

First Submitted

October 12, 2021

First Submitted That Met QC Criteria

October 20, 2021

First Posted (ACTUAL)

October 21, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 28, 2021

Last Update Submitted That Met QC Criteria

October 22, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on High Complex Anal Fistula

Clinical Trials on Cutting seton

3
Subscribe